Search research articles
Contact Us
Filters
Showing results (91-100 of 999) with videos related to
Page
of 100
Sort By:
Journal of Theoretical Biology
|
July 1, 1971
Note on the control of gene expression during development
E H Davidson
The American Journal of Cardiology
|
October 16, 2012
Cardio-diabetes: special considerations for the patient with diabetes and cardiovascular disease. Introduction
Michael H Davidson
The American Journal of Cardiology
|
August 16, 2005
Management of dyslipidemia in patients with complicated metabolic syndrome
Michael H Davidson
ACP Journal Club
|
September 2, 2005
Atorvastatin at 80 mg/d reduced major cardiovascular events more than atorvastatin at 10 mg/d in stable coronary heart disease
Michael H Davidson
Journal of Clinical Lipidology
|
May 7, 2013
Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction
Michael H Davidson
The American Journal of Cardiology
|
March 20, 2002
Strategies to improve Adult Treatment Panel III guideline adherence and patient compliance
Michael H Davidson
The Journal of Family Practice
|
November 7, 2009
An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Assessing cardiovascular risk one patient at a time
Michael H Davidson
Expert Opinion on Investigational Drugs
|
January 5, 2002
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia
Michael H Davidson
Proceedings of the Royal College of Physicians of Edinburgh
|
July 1, 1987
Experiences of an honorary librarian
C H Davidson
The American Journal of Cardiology
|
July 25, 2008
Introduction. U.S. incidence of coronary artery disease
Michael H Davidson
Page
of 100
Search research articles
Search
Showing results (91-100 of 999) with videos related to
Sort By:
Page
of 100
Journal of Theoretical Biology
|
July 1, 1971
Note on the control of gene expression during development
E H Davidson
The American Journal of Cardiology
|
October 16, 2012
Cardio-diabetes: special considerations for the patient with diabetes and cardiovascular disease. Introduction
Michael H Davidson
The American Journal of Cardiology
|
August 16, 2005
Management of dyslipidemia in patients with complicated metabolic syndrome
Michael H Davidson
ACP Journal Club
|
September 2, 2005
Atorvastatin at 80 mg/d reduced major cardiovascular events more than atorvastatin at 10 mg/d in stable coronary heart disease
Michael H Davidson
Journal of Clinical Lipidology
|
May 7, 2013
Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction
Michael H Davidson
The American Journal of Cardiology
|
March 20, 2002
Strategies to improve Adult Treatment Panel III guideline adherence and patient compliance
Michael H Davidson
The Journal of Family Practice
|
November 7, 2009
An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Assessing cardiovascular risk one patient at a time
Michael H Davidson
Expert Opinion on Investigational Drugs
|
January 5, 2002
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia
Michael H Davidson
Proceedings of the Royal College of Physicians of Edinburgh
|
July 1, 1987
Experiences of an honorary librarian
C H Davidson
The American Journal of Cardiology
|
July 25, 2008
Introduction. U.S. incidence of coronary artery disease
Michael H Davidson
Page
of 100